Non-Invasive Real-Time Hemodynamic monitor for the management of Hear Failure (LVEDP)
Heart failure (HF) affects more than 26 million people globally. More than 40% of persons diagnosed with HF will die within 5 years. HF accounts for nearly $30 billion in medical expenses yearly.
A major contributor to HF’s high mortality rate and cost of treatment is the difficulty in assessing the condition of the heart in real-time.
Left ventricular end-diastolic pressure (LVEDP), the left ventricle’s filling pressure, is an accepted index to assess the severity of HF.
CORALERT’S UNIQUE SOLUTION
CorAlert has developed an accurate, easy-to-use, noninvasive device for measuring LVEDP in real-time. Our device accurately estimates LVEDP along with other vital hemodynamic indices. The device supplies the physician a comprehensive hemodynamic profile allowing to accurately determine the exact type and severity of heart failure, and along with the cloud application allows for long term trend analysis and prediction of the patient prognosis.
CorAlert is conducting a clinical trial validating the accuracy of the device (Ziv Medical Center, Israel). The trial compares LVEDP measured in the Cath lab during routine elective catheterization to the LVEDP measured by CorAlert’s device. Correlation coefficient of the 2 measurements currently stands at >0.9 with p value <0.00013.